GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (OTCPK:YPHDF) » Definitions » Price-to-Owner-Earnings

Ypsomed Holding AG (Ypsomed Holding AG) Price-to-Owner-Earnings : 130.69 (As of Jun. 04, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ypsomed Holding AG Price-to-Owner-Earnings?

As of today (2024-06-04), Ypsomed Holding AG's share price is $362.00. Ypsomed Holding AG's Owner Earnings per Share (TTM) ended in Mar. 2024 was $2.77. It's Price-to-Owner-Earnings for today is 130.69.


The historical rank and industry rank for Ypsomed Holding AG's Price-to-Owner-Earnings or its related term are showing as below:

YPHDF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 30.36   Med: 61.63   Max: 177.13
Current: 130.91

During the past 13 years, the highest Price-to-Owner-Earnings of Ypsomed Holding AG was 177.13. The lowest was 30.36. And the median was 61.63.


YPHDF's Price-to-Owner-Earnings is ranked worse than
89.08% of 284 companies
in the Medical Devices & Instruments industry
Industry Median: 32.295 vs YPHDF: 130.91

As of today (2024-06-04), Ypsomed Holding AG's share price is $362.00. Ypsomed Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $6.42. Therefore, Ypsomed Holding AG's PE Ratio for today is 56.36.

As of today (2024-06-04), Ypsomed Holding AG's share price is $362.00. Ypsomed Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in was $6.42. Therefore, Ypsomed Holding AG's PE Ratio without NRI for today is 56.36.

During the past 13 years, Ypsomed Holding AG's highest PE Ratio without NRI was 804.45. The lowest was 22.84. And the median was 72.85.


Ypsomed Holding AG Price-to-Owner-Earnings Historical Data

The historical data trend for Ypsomed Holding AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Price-to-Owner-Earnings Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 91.46 123.70

Ypsomed Holding AG Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 91.46 - 123.70

Competitive Comparison of Ypsomed Holding AG's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Price-to-Owner-Earnings falls into.



Ypsomed Holding AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Ypsomed Holding AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=362.00/2.77
=130.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (OTCPK:YPHDF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Ypsomed Holding AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (Ypsomed Holding AG) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (Ypsomed Holding AG) Headlines

From GuruFocus

Full Year 2020 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2023 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2022 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2020 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2022 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2021 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2024 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Ypsomed Holding AG Earnings Call Transcript

By GuruFocus Research 03-08-2024